International Journal of Cardiovascular ResearchISSN: 2324-8602

Reach Us +1 850 900 2634

Case Report, Int J Cardiovasc Res Vol: 2 Issue: 1

Treatment of ACS in Diabetic Patients in Western Region of Saudi Arabia

Abdulhalim Jamal Kinsara*, Adel M Hasanin, Faisal A Batwa, Hattan J Moeminkha and Jamal A Kensara
King Faisal Cardiac Center, King Saud bin Abdulaziz University for Health Sciences, COM, King Abdul Aziz Medical City, Jeddah, Saudi Arabia
Corresponding author : Abdulhalim Jamal Kinsara
Assistant Professor, Head of Adult Cardiology, King Saud bin Abdulaziz University for Health Sciences, COM, King Abdul Aziz Medical City, King Faisal Cardiac Center, PO Box 9515, Jeddah 21423, Saudi Arabia
Tel: 966-2-624 0000, ext 25797; Fax: 966920008668
E-mail: [email protected]
Received: July 25, 2013 Accepted: September 16, 2013 Published: September 19, 2013
Citation: Kinsara AJ, Hasanin AM, Batwa FA, Moeminkhan HJ, Kensara JA (2013) Treatment of ACS in Diabetic Patients in Western Region of Saudi Arabia. Int J Cardiovasc Res 2:5. doi:10.4172/2324-8602.1000141

Abstract

Treatment of ACS in Diabetic Patients in Western Region of Saudi Arabia

In the setting of UA/NSTEMI-ACS, diabetes mellitus was found to be an independent predictor of mortality and DM patients were found to derive greater benefit than non-DM counterparts from aggressive antithrombotic therapy, early coronary angiography, and stent-based percutaneous coronary intervention.

Keywords: Diabetics; NSTEMI; ACS; Saudi; Jeddah; GP IIb/IIIa; MIDAS; Clopedogril/Ticlopidine

Track Your Manuscript

Share This Page

Media Partners